Actively Recruiting
The Impact of Social Media-delivered Chemotherapy-related Side Effects Education for Breast Cancer Patients Receiving First Time Chemotherapy
Led by Taipei Medical University Shuang Ho Hospital · Updated on 2025-01-24
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to find out if a standardized education program provided by pharmacists through social media can help breast cancer patients better understand chemotherapy-related side effects. The study focuses on patients receiving their first chemotherapy treatment and compares two ways of learning: watching an educational video versus receiving printed handouts. The goal is to see which method improves patients' knowledge about managing side effects. Participants are randomly assigned to one of two groups. One group receives a pharmacist-led education session including a video explaining side effects, their causes, prevention, management, and when to seek hospital care. This video lasts about 15 to 20 minutes and patients can watch it anytime during their treatment. The other group receives a brief explanation from pharmacists and printed handouts covering the same topics, with a visit lasting around 5 to 10 minutes. Both groups receive education during their first and second chemotherapy sessions. During the study, patients will complete questionnaires before and after the education sessions to assess their knowledge of side effect management and quality of life. The main measurement is a questionnaire with five questions given at the first and second chemotherapy visits, spaced 3 to 4 weeks apart. Researchers will monitor how well patients understand side effects and how this affects their quality of life. The trial lasts through the two chemotherapy sessions, with assessments at each visit.
CONDITIONS
Brief Title
The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Breast cancer patients aged 18 or older undergoing their first chemotherapy.
- Possess a smartphone and are able to watch videos on it.
You will not qualify if you...
- Unable to read or complete questionnaires in Chinese.
- Cognitive impairments.
- Pregnant women.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of chemotherapy treatment course (several weeks, typically 3 to 4 weeks per cycle)
Participants receive chemotherapy and education about chemotherapy side effects through either standardized pharmacist-provided videos or chemotherapy handouts. Education is provided at the first day of chemotherapy cycles, and participants can watch videos throughout their treatment course if assigned to the video group.
Visits on chemotherapy days including education sessions
Duration - Up to 4 weeks after initial chemotherapy session
Participants complete post-education questionnaires assessing knowledge and quality of life after chemotherapy education sessions during the treatment course.
1 to 2 questionnaire assessments during treatment
Trial Site Locations
Total: 1 location
1
Shuang Ho Hospital
New Taipei City, Taiwan
Actively Recruiting
Research Team
P
Pohung Lin, PharmD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here